Global Non-Invasive Prenatal Testing (NIPT) Market

Non-Invasive Prenatal Testing (NIPT) Market Size, Share, Growth Analysis, By product(cfDNA and FCMB), By End users(trisomy detection, microdeletion detection, sex chromosome, aneuploidy detection), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35J2080 | Region: Global | Published Date: February, 2024
Pages: 157 |Tables: 63 |Figures: 75

Non-Invasive Prenatal Testing (NIPT) Market Insights

Non-Invasive Prenatal Testing (NIPT) Market size was valued at USD 3.47 billion in 2019 and is poised to grow from USD 3.8 billion in 2023 to USD 7.92 billion by 2031, growing at a CAGR of 9.61% in the forecast period (2024-2031).

Non-invasive parenteral screening, sometimes referred to as non-invasive prenatal testing, is a developing genetic procedure that looks at foetal cell-free DNA present in the mother's blood serum to find common foetal aneuploidies. Early detection of genetic diseases such trisomy 21 (Down syndrome), trisomy 18 (Edward syndrome), trisomy 13 (Patau syndrome), and monosomy X is its primary goal (Turner syndrome). Additionally, it can identify the fetus's blood type and rhesus actor. NIPTs including MaterniT21 PLUS, Harmony, Panorama, NIFTY, PrenaTest, BambniTest, and others are currently offered on the international market.

The market is driven by an increase in NIPT reimbursements, a rise in the use of non-invasive procedures rather than invasive ones, and an increase in maternal age (which is linked to an increase in the incidence of chromosomal abnormalities in offspring). The introduction and development of cutting-edge, novel technologies as well as non-invasive parenteral testing items also contribute to the market's expansion. However, a shortage of qualified personnel, tight regulatory requirements, and ethical barriers hinder the approvals and marketing processes, which limits market growth. new development new markets in Asia-Pacific create potential for his market to flourish.

US Non-Invasive Prenatal Testing (NIPT) Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 3.47 billion

Largest Segment

cfDNA

Fastest Growth

cfDNA

Growth Rate

9.61% CAGR

Global Non-Invasive Prenatal Testing (NIPT) Market by product ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Non-Invasive Prenatal Testing (NIPT) Market Segmental Analysis

Global Non-Invasive Prenatal Testing (NIPT) Market is segmented based on the Product, end user, method, application, and region. Based on product, the market is segmented into consumable & reagents and instruments. Based on end-user, the market is segmented into hospital and clinical laboratories. Based on method, the market is segmented into cfDNA and FCMB. Based on application, the market is segmented into trisomy detection, microdeletion detection, sex chromosome, aneuploidy detection, & others. Based on Region it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Non-Invasive Prenatal Testing (NIPT) Market Analysis by Product

Based on Product, the market is dominated by the consumables and reagents sector. This is due to the market players releasing new test kits and the increase in lab-based tests conducted globally. In addition, one of the key factors fueling and driving the demand for reagents and consumables is the rising number of research and development activities for detecting genetic disorders. The adoption of these services is being driven globally by the technological developments in equipment and the growing cooperation among stakeholders to introduce extremely sensitive and affordable technologies for the detection of trisomy during pregnancies.

Non-Invasive Prenatal Testing (NIPT) Market Analysis by End user

Based on end user, The primary end-users of non-invasive diagnostics are clinical laboratories is anticipated to increase at the fastest rate. Clinical laboratories, which offer safe and efficient prenatal tests for chromosomal abnormalities compared to hospitals, are equipped with cutting-edge technology, opening up attractive growth opportunities for this market.

Global Non-Invasive Prenatal Testing (NIPT) Market by product, 2023 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Non-Invasive Prenatal Testing (NIPT) Market Regional Insights

North America dominated the global Non-Invasive Prenatal Testing (NIPT) market in 2021. This is a result of both the rising incidence of Down syndrome in babies and the growing use of noninvasive prenatal diagnostics. Furthermore, the expanding use of these exams in the US and Canada has been greatly influenced by players with a significant geographic presence in the US who provide advanced assessments. The Panorama test, created by Natera, is the only one that can distinguish between maternal and foetal DNA in the target chromosomes. It uses single-nucleotide polymorphism (SNP)-based technology to analyse DNA. In the following years, such innovative advancements are projected to increase usage and fuel market expansion in this region.

The market in Asia Pacific is anticipated to grow more rapidly than other regions. Early detection of chromosomal problems during pregnancy is becoming more and more popular in developing countries like China and India. It is anticipated that this will lead to the introduction of new goods and tests, along with domestic market participants stressing strategies like alliances and collaborations with international businesses.

Global Non-Invasive Prenatal Testing (NIPT) Market By Region, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Non-Invasive Prenatal Testing (NIPT) Market Dynamics

Non-Invasive Prenatal Testing (NIPT) Market Drivers

Need for Accurate and Sophisticated Screening to Boost Market Growth

  • The development of extremely sophisticated screening methods that are highly sensitive and accurate in the early detection of genetic abnormalities in newborns is a continuing priority for a number of businesses. Manufacturers are placing a lot of emphasis on the creation of cutting-edge noninvasive prenatal diagnostics and forming strategic alliances and collaborations to boost their market share. Significant advancements in the detection of aneuploidies in the neonatal population have been made possible by human genome sequencing. For instance, the biotechnology company Progenity, Inc. announced the release of the Resura Prenatal Diagnostic for Monogenic Disease in 2019. It is the first adaptable, noninvasive prenatal test for single-gene illnesses. Many nations are also implementing non-invasive prenatal screening protocols to identify chromosomal problems.

Non-Invasive Prenatal Testing (NIPT) Market Restraints

Lack of Skilled Worker to Hinder Market Growth

  • The use of these tests is likely to be constrained by their high cost, which makes them comparatively unaffordable in many developing nations. In India, the typical price of NIPT is between USD 350 and USD 400, according to a Future Medicine report. Their adoption in developing nations has been hampered by this. Growth would also be hampered by the general lack of knowledge about the risks of genetic disorders among the populace in emerging nations. Nevertheless, the decreased per capita healthcare spending and the inadequate test reimbursement policies are some other factors that could restrain the growth of the global noninvasive prenatal testing market.

Request Free Customization of this report to help us to meet your business objectives.

Non-Invasive Prenatal Testing (NIPT) Market Competitive Landscape

Global Non-Invasive Prenatal Testing (NIPT) Market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. Due to the broad range of product offers and strong distribution networks of big corporations in developed and developing countries, this market is consolidated. The top competitors in the market right now are Illumina, Inc., Sequenom Laboratories, LabCorp Inc., and Natera. It is anticipated that several aspects, such as active research and development efforts and a greater emphasis on producing cutting-edge products, will aid in maintaining their positions in the market. Other significant players, including YOURGENE HEALTH, Eurofins, LifeCodexx GmbH, F. Hoffmann-La Roche, and Perkin Elmer, Inc., intend to increase their market share through the implementation of fresher tactics, such as investments in the creation of innovative technologies for the early detection of chromosomal abnormalities and partnerships with key players and research institutions.

Non-Invasive Prenatal Testing (NIPT) Market Top Player's Company Profiles

  • Illumina, Inc.
  • Natera, Inc.
  • BGI Genomics Co., Ltd.
  • F. Hoffmann-La Roche AG
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies Inc.
  • GE Healthcare
  • Pacific Biosciences of California Inc.
  • Sequenom Laboratories (LabCorp)
  • Qiagen N.V.
  • LifeCodexx AG
  • NIPD Genetics
  • Yourgene Health plc
  • PerkinElmer Inc.
  • Eurofins LifeCodexx GmbH
  • Igenomix S.L.
  • Verinata Health, Inc.
  • Ariosa Diagnostics, Inc. (Roche)
  • SureGenomics, Inc.
  • Berry Genomics Co., Ltd.

Non-Invasive Prenatal Testing (NIPT) Market Recent Developments

  • In July 2021, A binding merger agreement was reached between Pacific Biosciences and Omniome, a San Diego-based business. Through creative market expansion strategies, this partnership will increase sequencing opportunities and benefit customers. Through its innovative methodology, Omniame will assist in obtaining an accurate short-read sequencing platform to penetrate significant, quickly expanding clinical application sectors in oncology and noninvasive prenatal testing.
  • In September 2022, Yourgene Health plc (“Yourgene”, AIM: YGEN), a leading international molecular diagnostics group, today announced it has received Health Sciences Authority (HSA) approval for its IONA® Nx NIPT Workflow in Singapore.

Non-Invasive Prenatal Testing (NIPT) Key Market Trends

  • In recent years, prenatal screening or testing has shifted its focus to non-invasive examinations, noting the therapeutic and economic benefits of these procedures. This move was made possible by the market participants' introduction of technologically sophisticated Non Invasive testing and their proven clinical efficacy. In many nations, rules have been put in place to make non-invasive prenatal diagnostics the norm rather than invasive procedures for prenatal screening. Non-invasive diagnostics, for instance, have become the norm for screening pregnant women in the Netherlands. Non-invasive testing has shown rapid rise in usage globally, despite the fact that invasive tests still have their applications in detecting particular conditions.

Non-Invasive Prenatal Testing (NIPT) Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.

According to our global non-invasive prenatal testing (nipt) market analysis, in terms of product, the consumables and reagents sector segment held a larger market share. This was caused by increased I lab tests numbers. And in terms of end user, clinical laboratories segment contribute to the market growth owing to its high preference by users. Moreover, continuous product development is driving the market expansion. Whereas, high cost of tests can hamper the market growth.

Report Metric Details
Market size value in 2023 USD 3.47 billion
Market size value in 2031 USD 7.92 billion
Growth Rate 9.61%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • product
    • cfDNA and FCMB
  • End users
    • trisomy detection, microdeletion detection, sex chromosome, aneuploidy detection, & others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Illumina, Inc.
  • Natera, Inc.
  • BGI Genomics Co., Ltd.
  • F. Hoffmann-La Roche AG
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies Inc.
  • GE Healthcare
  • Pacific Biosciences of California Inc.
  • Sequenom Laboratories (LabCorp)
  • Qiagen N.V.
  • LifeCodexx AG
  • NIPD Genetics
  • Yourgene Health plc
  • PerkinElmer Inc.
  • Eurofins LifeCodexx GmbH
  • Igenomix S.L.
  • Verinata Health, Inc.
  • Ariosa Diagnostics, Inc. (Roche)
  • SureGenomics, Inc.
  • Berry Genomics Co., Ltd.
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

Historical Year 2019

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Non-Invasive Prenatal Testing (NIPT) Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Non-Invasive Prenatal Testing (NIPT) Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Non-Invasive Prenatal Testing (NIPT) Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Non-Invasive Prenatal Testing (NIPT) Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Non-Invasive Prenatal Testing (NIPT) Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Non-Invasive Prenatal Testing (NIPT) Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Non-Invasive Prenatal Testing (NIPT) Market size was valued at USD 3.47 billion in 2019 and is poised to grow from USD 3.8 billion in 2023 to USD 7.92 billion by 2031, growing at a CAGR of 9.61% in the forecast period (2024-2031).

Non-Invasive Prenatal Testing (NIPT) Market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. Due to the broad range of product offers and strong distribution networks of big corporations in developed and developing countries, this market is consolidated. The top competitors in the market right now are Illumina, Inc., Sequenom Laboratories, LabCorp Inc., and Natera. It is anticipated that several aspects, such as active research and development efforts and a greater emphasis on producing cutting-edge products, will aid in maintaining their positions in the market. Other significant players, including YOURGENE HEALTH, Eurofins, LifeCodexx GmbH, F. Hoffmann-La Roche, and Perkin Elmer, Inc., intend to increase their market share through the implementation of fresher tactics, such as investments in the creation of innovative technologies for the early detection of chromosomal abnormalities and partnerships with key players and research institutions. 'Illumina, Inc.', 'Natera, Inc.', 'BGI Genomics Co., Ltd.', 'F. Hoffmann-La Roche AG', 'Thermo Fisher Scientific Inc.', 'Agilent Technologies Inc.', 'GE Healthcare', 'Pacific Biosciences of California Inc.', 'Sequenom Laboratories (LabCorp)', 'Qiagen N.V.', 'LifeCodexx AG', 'NIPD Genetics', 'Yourgene Health plc', 'PerkinElmer Inc.', 'Eurofins LifeCodexx GmbH', 'Igenomix S.L.', 'Verinata Health, Inc.', 'Ariosa Diagnostics, Inc. (Roche)', 'SureGenomics, Inc.', 'Berry Genomics Co., Ltd.'

The development of extremely sophisticated screening methods that are highly sensitive and accurate in the early detection of genetic abnormalities in newborns is a continuing priority for a number of businesses. Manufacturers are placing a lot of emphasis on the creation of cutting-edge noninvasive prenatal diagnostics and forming strategic alliances and collaborations to boost their market share. Significant advancements in the detection of aneuploidies in the neonatal population have been made possible by human genome sequencing. For instance, the biotechnology company Progenity, Inc. announced the release of the Resura Prenatal Diagnostic for Monogenic Disease in 2019. It is the first adaptable, noninvasive prenatal test for single-gene illnesses. Many nations are also implementing non-invasive prenatal screening protocols to identify chromosomal problems.

In recent years, prenatal screening or testing has shifted its focus to non-invasive examinations, noting the therapeutic and economic benefits of these procedures. This move was made possible by the market participants' introduction of technologically sophisticated Non Invasive testing and their proven clinical efficacy. In many nations, rules have been put in place to make non-invasive prenatal diagnostics the norm rather than invasive procedures for prenatal screening. Non-invasive diagnostics, for instance, have become the norm for screening pregnant women in the Netherlands. Non-invasive testing has shown rapid rise in usage globally, despite the fact that invasive tests still have their applications in detecting particular conditions.

North America dominated the Non-Invasive Prenatal Testing (NIPT) market in 2021. This is a result of both the rising incidence of Down syndrome in babies and the growing use of noninvasive prenatal diagnostics. Furthermore, the expanding use of these exams in the US and Canada has been greatly influenced by players with a significant geographic presence in the US who provide advanced assessments. The Panorama test, created by Natera, is the only one that can distinguish between maternal and foetal DNA in the target chromosomes. It uses single-nucleotide polymorphism (SNP)-based technology to analyse DNA. In the following years, such innovative advancements are projected to increase usage and fuel market expansion in this region.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Non-Invasive Prenatal Testing (NIPT) Market

Product ID: SQMIG35J2080

$5,300
BUY NOW GET FREE SAMPLE